We are live on ! Find out more
IBER

Ibere Pharmaceuticals
IBER

Delisted

IBER was delisted on the 1st of March, 2023.

Back to rankings

48 hedge funds and large institutions have $120M invested in Ibere Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 2 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

550% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 2

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

16% more capital invested

Capital invested by funds: $103M → $120M (+$17M)

4% more funds holding

Funds holding: 46 → 48 (+2)

Holders
48
Holders Change
+2
Holders Change %
+4.35%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
13
Reduced
2
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
+$7.05M
2
GCL
Glazer Capital LLC
New York
+$5.69M
3
FTCM
First Trust Capital Management
Illinois
+$5.35M
4
CM
Cohanzick Management
New York
+$3.44M
5
SCM
Saba Capital Management
New York
+$2.46M

Top Sellers

Rank Fund Capital Flow
1
Brown Advisory
Brown Advisory
Maryland
-$11.1M
2
KC
Kryger Capital
United Kingdom
-$3.94M
3
BCM
Basso Capital Management
Connecticut
-$1.67M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.47M
5
SCM
Shaolin Capital Management
Florida
-$1.34M
Name Holding Trade Value Shares
Change 		Change in
Stake
CF
26
Cantor Fitzgerald
New York
$1.11M – – –
Walleye Capital
27
Walleye Capital
New York
$1.09M – – –
Janus Henderson Group
28
Janus Henderson Group
United Kingdom
$1.05M +$1.04M +105,834 New
FTCM
29
Fir Tree Capital Management
New York
$815K – – –
Walleye Trading
30
Walleye Trading
New York
$793K – – –
WA
31
Whitebox Advisors
Minnesota
$746K – – –
CSS
32
Cubist Systematic Strategies
Connecticut
$698K +$695K +70,470 New
WRBC
33
W.R. Berkley Corp
Connecticut
$682K – – –
LCM
34
Lynwood Capital Management
Ontario, Canada
$509K – – –
Goldman Sachs
35
Goldman Sachs
New York
$505K -$49.3K -5,000 -9%
PI
36
PEAK6 Investments
Illinois
$496K – – –
Barclays
37
Barclays
United Kingdom
$486K – – –
MSU
38
Mizuho Securities USA
New York
$398K +$398K +40,333 New
DMKJ
39
David M. Knott Jr
$357K – – –
SAM
40
Silverback Asset Management
North Carolina
$297K +$296K +30,000 New
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
$291K +$290K +29,367 New
VF
42
Virtu Financial
New York
$250K +$249K +25,238 New
Capstone Investment Advisors
43
Capstone Investment Advisors
New York
$248K – – –
DIG
44
DeepCurrents Investment Group
New York
$176K – – –
DFCM
45
Dark Forest Capital Management
Puerto Rico
$154K -$59.6K -6,039 -28%
RCM
46
Robinson Capital Management
Michigan
$95K – – –
UBS Group
47
UBS Group
Switzerland
$21K – – –
EC
48
Elequin Capital
New York
$5K +$4.93K +500 New
Brown Advisory
49
Brown Advisory
Maryland
– -$11.1M -2,728,334 Closed
KC
50
Kryger Capital
United Kingdom
– -$3.94M -402,232 Closed
1
2
3

IBER Hedge Fund Activity: Q3 2022 in Review

48 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Ibere Pharmaceuticals (IBER) for Q3 2022, worth a combined $120M — up 16% from $103M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new IBER positions and 8 closed out — a net gain of 2 holders — while 13 added to existing stakes and 2 trimmed.

The largest buyer was Magnetar Financial, adding an estimated $7.05M. The largest seller was Brown Advisory, exiting entirely with an estimated $11.1M sold.

  • 48 institutional investors held Ibere Pharmaceuticals (IBER) as of Q3 2022, up from 46 in Q2 2022.
  • Funds reported $120M of Ibere Pharmaceuticals stock for Q3 2022, up 16% quarter-over-quarter.
  • 10 funds opened new Ibere Pharmaceuticals positions in Q3 2022 and 8 closed out, a net change of +2 holders.
  • The largest Ibere Pharmaceuticals buyer in Q3 2022 was Magnetar Financial, an estimated $7.05M added.
  • The largest Ibere Pharmaceuticals seller in Q3 2022 was Brown Advisory, an estimated $11.1M sold.

Based on aggregated 13F filings for Q3 2022.